CUPERTINO, Calif., Sept. 4, 2024 /PRNewswire/ — DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic…
Read More »Wainwright
DEER PARK, Ill., Aug. 22, 2024 (GLOBE NEWSWIRE) — Eton Pharmaceuticals (NASDAQ:), Inc (Eton or the Company) (Nasdaq: ETON), an…
Read More »